MS4A1

Afuco™ Anti-Human MS4A1 ADCC Therapeutic Antibody (BLX-301), ADCC Enhanced (AFC-515CL)

• Derivation: Humanized
• Species Reactivity: Human
• Type: ADCC enhanced antibody

Anti-Human MS4A1 Therapeutic Antibody (BLX-301) (TAB-537CL)

• Derivation: Humanized
• Species Reactivity: Human
• Type: Antibody

Anti-Human MS4A1 Therapeutic Antibody (Ibritumomab Tiuxetan) (TAB-H39)

• Derivation: Mouse
• Species Reactivity: Human
• Type: IgG1 - kappa
• Application: FC, IP, ELISA, Neut, FuncS, IF, ICC

Anti-Human CD20 Therapeutic Antibody (Afutuzumab) (TAB-133)

• Derivation: Humanized (from mouse)
• Species Reactivity: Human
• Type: IgG3 - kappa
• Application: IP, IF, FuncS, FC, Neut, ELISA, ICC

Anti-Human MS4A1 Therapeutic Antibody (Epitumomab) (TAB-H27)

• Derivation: Mouse
• Species Reactivity: Human
• Type: IgG2a
• Application: IP, IF, FuncS, FC, Neut, ELISA, ICC

Anti-Human CD20 Therapeutic Antibody (Ofatumumab) (TAB-028)

• Derivation: Human
• Species Reactivity: Human
• Type: IgG1 - kappa
• Application: FC, IP, ELISA, Neut, FuncS, IF, IHC

Anti-Human CD20 Therapeutic Antibody (Ibritumomab) (TAB-001)

• Derivation: Mouse
• Species Reactivity: Human
• Type: IgG1 - kappa
• Application: ELISA, IP, FC, FuncS, IF, Neut

Anti-MS4A1 Therapeutic Antibody (Technetium (99MTC) Nofetumomab Merpentan) (TAB-711)

• Derivation: Mouse
• Species Reactivity: Human
• Type: Fab - G2b - kappa
• Application: FC, IP, ELISA, Neut, FuncS, IF, ICC

Anti-CD20 Therapeutic Antibody (Ocaratuzumab) (TAB-771)

• Derivation: Humanized (from mouse)
• Species Reactivity: Human
• Type: IgG1 - kappa
• Application: IF, IP, Neut, FuncS, ELISA, FC, ICC

Anti-Human CD20 Therapeutic Antibody (Tositumomab) (TAB-017)

• Derivation: Mouse
• Species Reactivity: Human
• Type: IgG2a - lambda
• Application: Neut, ELISA, IF, IP, FuncS, FC, ICC

Anti-Human CD20 Therapeutic Antibody (TAB-207)

• Derivation: Chimeric (mouse/human)
• Species Reactivity: Human
• Type: IgG1 - kappa
• Application: ELISA, IP, FC, FuncS, Neut, IF, ICC

Anti-Human MS4A1 Therapeutic Antibody (Obinutuzumab) (TAB-H51)

• Derivation: Humanized (from mouse)
• Species Reactivity: Human
• Type: IgG1 - kappa
• Application: ELISA, FC, IP, FuncS, IF, Neut, WB

Anti-Human CD20 Therapeutic Antibody (Rituximab) (TAB-016)

• Derivation: Chimeric (mouse/human)
• Species Reactivity: Human
• Type: IgG1 - kappa
• Application: IF, IP, Neut, FuncS, ELISA, FC, WB

Anti-CD20 Therapeutic Antibody (Ocrelizumab) (TAB-772)

• Derivation: Humanized (from mouse)
• Species Reactivity: Human
• Type: IgG1
• Application: ELISA, IP, FC, FuncS, Neut, IF, ICC

Recombinant Anti-human MS4A1 VHH Single Domain Antibody (NAB-913-sdAb)

• Species Reactivity: Human
• Type: Llama VHH
• Application: IP, FC, ChiP, Neut

Anti-Human MS4A1 Therapeutic Antibody (TAB-0001CL)

• Derivation: Human
• Type: Human antibody
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (3637) (TAB-1699CL-S(P))

• Derivation: Humanized
• Type: Humanized antibody
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody (Table 1) (TAB-1676CL)

• Type: Fully human antibody

Anti-Human MS4A1 Therapeutic Antibody (1237) (TAB-1637CL)

• Derivation: Humanized
• Type: Humanized antibody
• Application: ADCC, CDC

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (1635) (TAB-1698CL-S(P))

• Derivation: Humanized
• Type: Humanized antibody
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody (GNR-006) (TAB-1675CL)

• Derivation: Chimeric (murine/human)
• Type: Chimeric antibody (mouse/human)
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody (1236) (TAB-1636CL)

• Derivation: Humanized
• Type: Humanized antibody
• Application: ADCC, CDC

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (ch1F5) (TAB-1633CL-S(P))

• Derivation: Chimeric (mouse/human)
• Type: Chimeric antibody (mouse/human)
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (1535) (TAB-1697CL-S(P))

• Derivation: Humanized
• Type: Humanized antibody
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody (101) (TAB-1674CL)

• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody (BVX20) (TAB-1635CL)

• Derivation: Humanized
• Type: Humanized antibody
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (1634) (TAB-1696CL-S(P))

• Derivation: Humanized
• Type: Humanized antibody
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody (hu8E4) (TAB-1672CL)

• Derivation: Humanized
• Type: Humanized antibody
• Application: Inhib, CDC, ADCC, Apop, FuncS

Anti-Human MS4A1 Therapeutic Antibody (ch1F5-DXL) (TAB-1634CL)

• Derivation: Chimeric (mouse/human)
• Type: Chimeric antibody (mouse/human)
• Application: FC, Apop, CDC, ADCC, Inhib

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (1534) (TAB-1695CL-S(P))

• Derivation: Humanized
• Type: Humanized antibody
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (1F5) (TAB-1632CL-S(P))

• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody (c1K1228) (TAB-1671CL)

• Derivation: Chimeric (mouse/human)
• Type: Chimeric antibody (mouse/human)
• Application: CDC

Anti-Human MS4A1 Therapeutic Antibody (ch1F5) (TAB-1633CL)

• Derivation: Chimeric (mouse/human)
• Type: Chimeric antibody (mouse/human)
• Application: FC, Apop, CDC, ADCC, Inhib

Anti-Human MS4A1 Therapeutic Antibody (c1K0924) (TAB-1670CL)

• Derivation: Chimeric (mouse/human)
• Type: Chimeric antibody (mouse/human)
• Application: CDC

Anti-Human MS4A1 Therapeutic Antibody (1F5) (TAB-1632CL)

• Application: FC

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (ch1F5-DXL) (TAB-1634CL-S(P))

• Derivation: Chimeric (mouse/human)
• Type: Chimeric antibody (mouse/human)
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody (1238) (TAB-1638CL)

• Derivation: Humanized
• Type: Humanized antibody
• Application: ADCC, CDC

Anti-Human MS4A1 Therapeutic Antibody (IBI-301) (TAB-1677CL)

• Derivation: Humanized
• Type: Humanized antibody
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (R92-3-1) (TAB-1700CL-S(P))

• Derivation: Chimeric (mouse/human)
• Type: Chimeric antibody (mouse/human)
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody (1588) (TAB-1639CL)

• Derivation: Humanized
• Type: Humanized antibody
• Application: ADCC, CDC, Apop

Anti-Human MS4A1 Therapeutic Antibody (H19L3) (TAB-1678CL)

• Type: Fully human antibody
• Application: ADCC, CDC

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (2H7) (TAB-1701CL-S(P))

• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (BVX20) (TAB-1635CL-S(P))

• Derivation: Humanized
• Type: Humanized antibody
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody (1589) (TAB-1640CL)

• Derivation: Humanized
• Type: Humanized antibody
• Application: ADCC, CDC, Apop, FuncS

Anti-Human MS4A1 Therapeutic Antibody (H19L15) (TAB-1679CL)

• Type: Fully human antibody
• Application: ADCC, CDC

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (1236) (TAB-1636CL-S(P))

• Derivation: Humanized
• Type: Humanized antibody
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody (1590) (TAB-1641CL)

• Derivation: Humanized
• Type: Humanized antibody
• Application: ADCC, CDC, Apop

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (Humanized 2H7) (TAB-1702CL-S(P))

• Derivation: Humanized
• Type: Humanized antibody
• Application: For in vitro and in vivo research use. Not intended for any applications in human.

Anti-Human MS4A1 Therapeutic Antibody (H11L10) (TAB-1680CL)

• Type: Fully human antibody
• Application: ADCC, CDC

Anti-Human MS4A1 Therapeutic Antibody scFv Fragment (1237) (TAB-1637CL-S(P))

• Derivation: Humanized
• Type: Humanized antibody
• Application: For in vitro and in vivo research use. Not intended for any applications in human.